egnite Brings Renowned Interventional Cardiologist, Rahul Sharma, onto Executive Team as Senior Medical Advisor

egnite Brings Renowned Interventional Cardiologist, Rahul Sharma, onto Executive Team as Senior Medical Advisor

ALISO VIEJO, Calif. – February 16, 2023 –  egnite, Inc., a leading digital-health company in the field of cardiovascular care, is proud to announce the appointment of Rahul P. Sharma, MD, MBBS, FRACP, as its new Senior Medical Advisor.

A renowned interventional cardiologist, Sharma brings a wealth of knowledge and expertise to egnite’s executive team. With over a decade of experience in structural heart disease and transcatheter valve therapy, Sharma will play a key role in shaping egnite’s clinical strategy, advancing the organization’s mission to improve patient care through digital health technologies.

Sharma has a proven track record of success in advancing the field of cardiovascular medicine as an investigator in several national multi-center clinical trials and as a co-author of numerous peer-reviewed scientific articles. As Senior Medical Advisor, Sharma will help shape the real-world evidence strategy for egnite, working closely with healthcare providers to drive improved patient care and outcomes through egnite’s innovative technologies. Sharma will also drive key product evolutions as he advises egnite on technology enhancements that support best-in-class cardiovascular programs and help generate progressive clinical science that advances medicine.  

“We are thrilled to welcome Rahul to the egnite team,” said Joel Portice, CEO of egnite. “His extensive experience and deep knowledge of the clinical landscape will be invaluable as we develop and launch innovative solutions to improve patient outcomes.”

Based in the heart of Silicon Valley, Sharma has fused his passion for science and innovation by working in collaboration with several health tech companies. He is also a co-founder of Synchron, a leading implantable brain-computer interface company looking to restore the lives of patients with neurological diseases. Sharma is currently the Director of Structural Interventions, Associate Director of the Cardiac Catheterization Laboratory, and the Associate Professor of Medicine at a large academic institution.

“I am excited to join the egnite team during the next phase of growth for the company,” said Sharma. “I am committed to using my expertise to improve patient outcomes and make a meaningful difference in the lives of those we serve.”

About egnite, Inc.

egnite is a visionary digital health company born from the innovation of Edwards Lifesciences, committed to advancing the health of our society through innovative cardiovascular solutions. egnite uses AI-driven algorithms and big data to produce business intelligence for healthcare, elevating the role of data in critical decisions. The company partners with leading hospitals and life sciences providers to transformative care delivery for cardiovascular patients. The company is based in Aliso Viejo, Calif., for more information, visit www.egnitehealth.com.

Related Articles

Real-World Evidence

Acute Valve Syndrome in Aortic Stenosis

“These findings are extremely important and complementary to the recently presented EARLY TAVR Trial, published in the NEJM. The absence of symptoms was traditionally considered a sign of relative safety. However, this study shows how frequent acute valve syndrome is in patients undergoing AVR, and how patients would benefit greatly

Press

egnite Inc.’s Real-World Evidence Demonstrates Improved Survival in Asymptomatic Aortic Stenosis Patients Undergoing Aortic Valve Replacement (AVR)

egnite Inc.’s Real-World Evidence Demonstrates Improved Survival in Asymptomatic Aortic Stenosis Patients Undergoing Aortic Valve Replacement (AVR) Key Findings Demonstrate 3x Improved Survival for Asymptomatic AS Patients Undergoing AVR versus AS Patients Presenting with Acute Valve Syndrome ALISO VIEJO, Calif. – October 28, 2024 – egnite, Inc., a leading cardiovascular digital

Press

egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference

egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.